CONTRATO
Contract L381
Desarrollo de comprimidos de liberacion sostenida de un farmaco para el tratamiento de la esclerosis multiple.
Funder: NEURAXPHARM ARZNEIMITTEL GMBH
Call: (NEURAXPHARM ARZNEIMITTEL GMBH)
date_range
Duration: from 20 September 2017 to 15 September 2019
(23 months)
Finished
€144,900.00
Of European scope.
